Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.

MLA

Kim, Jung, et al. “Prevalence of Pathogenic/Likely Pathogenic Variants in the 24 Cancer Genes of the ACMG Secondary Findings v2.0 List in a Large Cancer Cohort and Ethnicity-Matched Controls.” Genome Medicine, vol. 10, no. 1, Dec. 2018, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s13073-018-0607-5.

APA

Kim, J., Frone, M. N., Gianferante, M., Khincha, P., McMaster, M. L., McReynolds, L. J., Pemov, A., Pinheiro, M., Alter, B. P., Gadalla, S. M., Greene, M. H., Loud, J., Mirabello, L. J., Savage, S. A., Goldstein, A. M., Stewart, D. R., Wegman-Ostrosky, T., Achatz, M. I., de Andrade, K. C., & Fortes, F. P. (2018). Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls. Genome Medicine, 10(1), N.PAG. https://doi.org/10.1186/s13073-018-0607-5

Chicago

Kim, Jung, Megan N. Frone, Matthew Gianferante, Payal Khincha, Mary L. McMaster, Lisa J. McReynolds, Alexander Pemov, et al. 2018. “Prevalence of Pathogenic/Likely Pathogenic Variants in the 24 Cancer Genes of the ACMG Secondary Findings v2.0 List in a Large Cancer Cohort and Ethnicity-Matched Controls.” Genome Medicine 10 (1): N.PAG. doi:10.1186/s13073-018-0607-5.